Results 141 to 150 of about 16,205 (199)

Azathioprine co-therapy with allopurinol for inflammatory bowel disease: Trials and tribulations [PDF]

, 2012
Ansari, Azhar R., Duley, John A.
core  

The fate of thiopurine metabolites after switching to low-dose thiopurine with allopurinol or thioguanine in IBD patients: A retrospective analysis. [PDF]

Br J Clin Pharmacol
Bayoumy AB, D'Agnolo HMA, de Boer NKH, Mulder CJJ, Derijks LJJ.   +4 more
europepmc   +1 more source

A large-scale comparison of clinical outcomes to IBD therapies in White and South Asian ethnicities. [PDF]

EClinicalMedicine
Balarajah S, Martinez-Gili L, Alexander JL, Mullish BH, Perry RW, Li JV, Marchesi JR, Parkes M, Orchard TR, Hicks LC, Williams HRT, UK IBD BioResource Investigators.   +11 more
europepmc   +1 more source

Clinical Utility and Cost-Effectiveness of Pretreatment NUDT15 Pharmacogenetic Testing to Prevent Thiopurine-Induced Myelosuppression: A Genotype-First Reverse Phenotyping Cohort Study Within the UK NIHR Inflammatory Bowel Disease Bioresource. [PDF]

Aliment Pharmacol Ther
Roberts C, Peters J, Sazonvos A, Goodman N, Sharip M, Smith R, Bishara M, Bewshea C, Lin S, Chanchlani N, Hodges P, Badrulhisham F, Saifuddin A, Carlson S, Centritto A, Marley A, Saad M, Sethi-Aora K, White L, Abdelmeguid A, Pele L, Sebastian S, Selinger C, Irving P, Fachal L, Walker G, Palmer R, Kennedy N, Houghton J, Doona M, Lamb C, Hyde C, Parkes M, Goodhand J, Ahmad T.   +34 more
europepmc   +1 more source

Cancer incidence in patients with ulcerative colitis naïve to or treated with thiopurine and targeted therapies-a cohort study 2007 to 2022 with comparison to the general population. [PDF]

J Crohns Colitis
Everhov ÅH, Askling J, Söderling J, Halfvarson J, Eriksson J, Smedby KE, Ludvigsson JF, Sørensen HT, Olén O.   +8 more
europepmc   +1 more source

The Changing Landscape in Patients With Crohn's Disease. [PDF]

United European Gastroenterol J
Ong S, Seenan JP.
europepmc   +1 more source

The NUDIX hydrolase NUDT5 influences purine nucleotide metabolism and thiopurine pharmacology. [PDF]

J Clin Invest
Kager L, Boztug K.
europepmc   +1 more source

High Rate of Seroprotection With Heplisav-B in Patients With Inflammatory Bowel Disease. [PDF]

J Clin Gastroenterol
Hegde Y, Lazarus SK, Farraye FA, Hollnagel F, Hayney MS, Caldera F.   +5 more
europepmc   +1 more source

Katabolismus des Molybdän-Cofaktors - Identifikation der endogenen Thiopterin-Methyltransferase [PDF]

, 2014
Csaszar, Julika
core